Imagine a world of endless meadow and hills, lit by the glow of a nearby gas giant. Here, over hundreds of millions of years, birds evolve into a dizzying array of strange shapes and forms reminiscent of the grandeur...
This article first appeared in IndiaTogether The COVID-19 experience has brought attention to the importance of science, technology and innovation. Researchers facilitated the rapid understanding of a new virus. Technology underpinned efforts for curbing the spread of the disease. Entrepreneurship...
Will India be able to cover its target population for COVID-19 vaccination? What issues is India facing during vaccination? Which vaccines are being approved? Sunila Dixit and Shambhavi Naik discuss these questions and more.
The DNA Technology (Use and Application) Regulation Bill has been listed for consideration in the Budget session. Shambhavi Naik and Sunila Dixit discuss the bill’s benefits and risks in light of the recently tabled Parliamentary Standing Committee’s report.
The year 2020 has emphasised the need to pay attention to health and life sciences in India. There is an urgent requirement to increase public funding and facilitate private sector funding in both fundamental and translational research. However, along with...
The Draft 5th Science, Technology and Innovation Policy 2020 outlines a grand vision for Indian science over the coming years. But is it a feasible one? Aditya Ramanathan and Shambhavi Naik discuss the ideas proposed in this policy, and...
On 27 January, All Things Policy, the world’s only daily public policy podcast, marked 500 episodes. Manoj Kewalramani talks to Aditya Ramanathan and Anirudh Kanisetti about the surprising origins of the podcast, its evolution over the last two years, and...
As India launches the first phase of its COVID-19 vaccination programme, Shambhavi Naik talks to Rohan Seth about domestic and international developments, India’s vaccine diplomacy, and the crucial question of efficacy.
(This article was first published in The Wire) 2020 was a disaster year for almost everyone – but it was a unique opportunity for Indian science. An oft-neglected enterprise, it received unprecedented attention as scientists tried to innovate in the...
India’s approval of two COVID-19 vaccines for emergency use has received mixed responses. Shambhavi Naik, Anirudh Kanisetti and Sunila Dixit discuss the approval process, the possible consequences of speeding things up and the potential impact on public confidence.
